Skip to Content

Beacon-Neuro.AI receives FDA Breakthrough Device Designation for BeaconPredict™

Alex Yahanda 6/3/26 Alex Yahanda 6/3/26

Beacon-Neuro.AI receives FDA Breakthrough Device Designation for BeaconPredict™

Read More

Beacon-Neuro.AI

4340 Duncan Ave.
Suite 287
St. Louis, MO 63110-1110

Info@beacon-neuro.ai

linkedin.com/company/beacon-neuro-ai/